MNPR SCHEDULE 13G/A: SEC filing
An institutional holder
Filed with the SEC on · accession 0002060757-26-000047
MNPR filed a SCHEDULE 13G/A (schedule 13g/a) with the SEC on Aug 12, 2026. An institutional holder filed an amended Schedule 13G disclosing its beneficial ownership position in Monopar Therapeutics. The stock moved +0.4% by the first close after the filing.
Summary of the filing
An institutional holder filed an amended Schedule 13G disclosing its beneficial ownership position in Monopar Therapeutics. The filing indicates a passive investment stake with no stated intent to influence company control.
Key details
How MNPR stock reacted
Close before
$114.46
Aug 11, 2026
First close after
+0.38%
$114.90
5 trading days
+4.01%
$119.05
Since filing
-37.60%
$71.42
✦ Ask GOAX AI about this filing — what it means for MNPR, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for MNPR?
Click hereFrequently asked questions
What did MNPR file with the SEC on Aug 12, 2026?
MNPR filed a SCHEDULE 13G/A (SEC filing). An institutional holder filed an amended Schedule 13G disclosing its beneficial ownership position in Monopar Therapeutics. The filing indicates a passive investment stake with no stated intent to influence company control.
How do I read a SCHEDULE 13G/A?
A report the company filed with the SEC (the US market regulator). Start with the summary, then the key amounts and names. Compare it with the company’s earlier filings.
Why are SEC filings important?
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A SCHEDULE 13G/A (schedule 13g/a): A report the company filed with the SEC (the US market regulator).
How did MNPR stock react to this filing?
MNPR closed at $114.46 before the filing and $114.90 on Aug 12, 2026 (+0.38%). Five trading days later: $119.05 (+4.01%).
Other MNPR SEC filings
- SCHEDULE 13G · SEC filingOct 27, 2026
- SCHEDULE 13G/A · SEC filingAug 12, 2026
- 8-K · Guidance raiseAug 12, 2026
- 10-Q · SEC filingAug 12, 2026
- 8-K · Fda approvalJul 22, 2026
- 144 · Insider sale plannedJul 10, 2026
- 8-K · Fda approvalJun 30, 2026
- 8-K · Fda approvalJun 26, 2026
- 8-K · SEC filingJun 23, 2026
- 8-K · Fda approvalMay 19, 2026
Get alerts when MNPR files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days